文献
J-GLOBAL ID:201802242376192689
整理番号:18A0260117
低用量リバロキサバンとの臨床的に有意な出血と急性冠動脈症候群(GEMINI ACS 1)におけるP2Y12阻害に加えて,アスピリン:二重盲検,多施設,無作為化試験【Powered by NICT】
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
著者 (28件):
Ohman E Magnus
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA)
,
Roe Matthew T
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA)
,
Steg P Gabriel
(DHU FIRE, Universite Paris-Diderot, AP-HP and Inserm U-1148, Paris, France)
,
Steg P Gabriel
(NHLI Royal Brompton Hospital, Imperial College London, London, UK)
,
James Stefan K
(Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden)
,
Povsic Thomas J
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA)
,
White Jennifer
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA)
,
Rockhold Frank
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA)
,
Plotnikov Alexei
(Janssen Research and Development, Raritan, NJ, USA)
,
Mundl Hardi
(Bayer AG, Wuppertal, Germany)
,
Strony John
(Janssen Research and Development, Raritan, NJ, USA)
,
Sun Xiang
(Janssen Research and Development, Raritan, NJ, USA)
,
Husted Steen
(Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark)
,
Tendera Michal
(3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland)
,
Montalescot Gilles
(Institut de Cardiologie, Groupe Hospitalier Pitie-Salpetriere, Paris, France)
,
Bahit M Cecilia
(INECO Neurociencias Orono, Rosario, Santa Fe, Argentina)
,
Ardissino Diego
(Divisione di Cardiologia, Policlinico San Matteo, Pavia, Italy)
,
Bueno Hector
(Spanish National Centre for Cardiovascular Research, Madrid, Spain)
,
Claeys Marc J
(University Hospital Antwerp, Edegem, Belgium)
,
Nicolau Jose C
(Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil)
,
Cornel Jan H
(Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar and Dutch Network for Cardiovascular Research (WCN), Netherlands)
,
Goto Shinya
(Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan)
,
Kiss Robert Gabor
(Department of Cardiology, Military Hospital, Budapest, Hungary)
,
Gueray UEmit
(Numune Education and Research Hospital, Department of Cardiology, Ankara, Turkey)
,
Park Duk-Woo
(Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea)
,
Bode Christoph
(University of Freiburg, Freiburg, Germany)
,
Welsh Robert C
(Mazankowski Alberta Heart Institute and University of Alberta, Edmonton, AB, Canada)
,
Gibson C Michael
(PERFUSE Study Group, Beth Israel Deaconess Hospital, Harvard Medical School, Boston, MA, USA)
資料名:
Lancet
(Lancet)
巻:
389
号:
10081
ページ:
1799-1808
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)